These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20180649)

  • 1. Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid.
    Oikonomopoulou K; Batruch I; Smith CR; Soosaipillai A; Diamandis EP; Hollenberg MD
    Biol Chem; 2010 Apr; 391(4):381-90. PubMed ID: 20180649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids.
    Oikonomopoulou K; Hansen KK; Baruch A; Hollenberg MD; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):747-56. PubMed ID: 18627291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier.
    Oikonomopoulou K; Diamandis EP; Hollenberg MD
    Biol Chem; 2010 Apr; 391(4):299-310. PubMed ID: 20180639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
    Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
    Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
    Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
    Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids.
    Yousef GM; Kapadia C; Polymeris ME; Borgono C; Hutchinson S; Wasney GA; Soosaipillai A; Diamandis EP
    Biochim Biophys Acta; 2003 Jul; 1628(2):88-96. PubMed ID: 12890555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex formation between human kallikrein 13 and serum protease inhibitors.
    Kapadia C; Yousef GM; Mellati AA; Magklara A; Wasney GA; Diamandis EP
    Clin Chim Acta; 2004 Jan; 339(1-2):157-67. PubMed ID: 14687906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human kallikrein 8, a novel biomarker for ovarian carcinoma.
    Kishi T; Grass L; Soosaipillai A; Scorilas A; Harbeck N; Schmalfeldt B; Dorn J; Mysliwiec M; Schmitt M; Diamandis EP
    Cancer Res; 2003 Jun; 63(11):2771-4. PubMed ID: 12782581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human kallikrein related peptidases 6 and 13 in combination withCA125 is a more sensitive test for ovarian cancer than CA125 alone.
    White NM; Mathews M; Yousef GM; Prizada A; Fontaine D; Ghatage P; Popadiuk C; Dawson L; Doré JJ
    Cancer Biomark; 2009; 5(6):279-87. PubMed ID: 20037204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study.
    Oikonomopoulou K; Scorilas A; Michael IP; Grass L; Soosaipillai A; Rosen B; Murphy J; Diamandis EP
    Tumour Biol; 2006; 27(2):104-14. PubMed ID: 16557045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma.
    Luo LY; Shan SJ; Elliott MB; Soosaipillai A; Diamandis EP
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):742-50. PubMed ID: 16467084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interdependence of kallikrein-related peptidases in proteolytic networks.
    Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V
    Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
    Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel overexpression of seven kallikrein genes in ovarian cancer.
    Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients.
    Komatsu N; Saijoh K; Kuk C; Liu AC; Khan S; Shirasaki F; Takehara K; Diamandis EP
    Exp Dermatol; 2007 Jun; 16(6):513-9. PubMed ID: 17518992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.
    Graves LE; Ariztia EV; Navari JR; Matzel HJ; Stack MS; Fishman DA
    Cancer Res; 2004 Oct; 64(19):7045-9. PubMed ID: 15466198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
    Gunawardana CG; Kuk C; Smith CR; Batruch I; Soosaipillai A; Diamandis EP
    J Proteome Res; 2009 Oct; 8(10):4705-13. PubMed ID: 19663500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
    Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the kallikrein-related peptidases for drug development.
    Sotiropoulou G; Pampalakis G
    Trends Pharmacol Sci; 2012 Dec; 33(12):623-34. PubMed ID: 23089221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.
    White NM; Bui A; Mejia-Guerrero S; Chao J; Soosaipillai A; Youssef Y; Mankaruos M; Honey RJ; Stewart R; Pace KT; Sugar L; Diamandis EP; Doré J; Yousef GM
    Biol Chem; 2010 Apr; 391(4):411-23. PubMed ID: 20180642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.